Xylo-oligosaccharides with high value could be obtained by acidolysis of lignocellulosic biomass with acetic acid, which was an urgent problem to solve for the separation of acetic acid from crude xylo-oligosaccharides solution. Four neutralizers, CaCO3, CaO, Na2CO3, and NaOH, were used for in situ chemically locking the acetic acid in the acidolyzed hydrolysate of corncob. The chemically locked hydrolysate was analyzed and compared using vacuum evaporation and spray drying. After CaCO3, CaO, Na2CO3, and NaOH treatment, the locking rates of acetic acid were 92.62%, 94.89%, 95.05%, and 95.58%, respectively, and 39.55 g, 41.13 g, 41.78 g, and 41.87 g of the compound of xylo-oligosaccharide and acetate were obtained. Sodium neutralizer had lesser effect on xylo-oligosaccharide content, and Na2CO3 was the best chemical for locking acetic acid among these four neutralizers. This process provides a novel method for effectively utilizing acetic acid during the industrial production of xylo-oligosaccharides via acetic acid.Previous studies have shown that face-voice matching accuracy is more consistently above chance for dynamic (i.e. speaking) faces than for static faces. This suggests that dynamic information can play an important role in informing matching decisions. We initially asked whether this advantage for dynamic stimuli is due to shared information across modalities that is encoded in articulatory mouth movements. Participants completed a sequential face-voice matching task with (1) static images of faces, (2) dynamic videos of faces, (3) dynamic videos where only the mouth was visible, and (4) dynamic videos where the mouth was occluded, in a well-controlled stimulus set. Surprisingly, after accounting for random variation in the data due to design choices, accuracy for all four conditions was at chance. Crucially, however, exploratory analyses revealed that participants were not responding randomly, with different patterns of response biases being apparent for different conditions. Our findings suggest that face-voice identity matching may not be possible with above-chance accuracy but that analyses of response biases can shed light upon how people attempt face-voice matching. We discuss these findings with reference to the differential functional roles for faces and voices recently proposed for multimodal person perception. This was a Japanese subpopulation analysis of MONARCH 2, a double-blind, randomized, placebo-controlled, phase 3 study of abemaciclib plus fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (ABC). Eligible women had progressed on (neo)adjuvant endocrine therapy (ET), ≤ 12months from end of adjuvant ET, or on first-line ET for ABC, and had not received chemotherapy for ABC. Patients were randomized 21 to receive abemaciclib or placebo plus fulvestrant. The primary endpoint was progression-free survival (PFS). Secondary endpoints included overall survival (OS), pharmacokinetics (PK), health-related quality of life (HRQoL), and safety. In Japan, 95 patients were randomized (abemaciclib, n = 64; placebo, n = 31). At final PFS analysis (February 14, 2017), median PFS was 21.2 and 14.3months, respectively, in the abemaciclib and placebo groups (hazard ratio 0.672; 95% confidence interval 0.380-1.189). Abemaciclib had a higher objective response rate (37.5%) than placebo (12.9%). PK and safety profiles for Japanese patients were consistent with those of the overall population, without clinically meaningful differences across most HRQoL dimensions evaluated. The most frequent adverse events in the abemaciclib versus placebo groups were diarrhea (95.2 versus 25.8%), neutropenia (79.4 versus 0%), and leukopenia (66.7 versus 0%). At a second data cutoff (June 20, 2019), median OS was not reached with abemaciclib and 47.3months with placebo (hazard ratio 0.755; 95% confidence interval 0.390-1.463). Results of the Japanese subpopulation were consistent with the improved clinical outcomes and manageable safety profile observed in the overall population. NCT02107703; U.S. National Library of Medicine https//clinicaltrials.gov/ct2/show/NCT02107703 . NCT02107703; U.S. National Library of Medicine https//clinicaltrials.gov/ct2/show/NCT02107703 .Coronavirus disease 2019 (COVID-19) has emerged as a pandemic across the world. Hypercoagulability status in COVID-19 is one of the causes of complication from severe COVID-19 with a high risk of arterial thrombosis. Acute Limb Ischemia is a vascular emergency caused by sudden decrease in the arterial perfusion. We report the case of a 53-year-old male patient with COVID-19 Pneumonia, diagnosed with Acute Limb Ischemia. From clinical examination, which included anamnesis, physical examination, and laboratory results as well as chest X-rays, a suspicion of Acute Limb Ischemia was found in a patient with COVID-19 pneumonia. The SARS-CoV-2 real time PCR examination showed positive results. https://www.selleckchem.com/products/sr-0813.html In this patient, the diagnosis of Acute Limb Ischemia with Covid-19 Pneumonia was established through a multidisciplinary approach covering the fields of pulmonology, cardiology, and thoracic and cardiovascular surgery.TiO2 nano particles (NPs) are one of the most produced nanoparticles in the world which are increasingly being released in to the soil. Soils are exposed to various level of concentration of TiO2 NPs, which has raised concern over the adverse influence on soil microbial community, in turn on ecosystem functions. Although, increasing number of studies on ecotoxicological effect of TiO2 NPs are coming up recently, however, a common conscience has yet to be reached regarding the impact of TiO2 NPs on soil microbial community and processes. Moreover, very few studies have targeted soil enzymes which are being considered as sensitive indicator of soil health. Therefore, the present study has been carried out to estimate the ecotoxicological effect of various doses of TiO2 NPs (5, 10, 20, 40, 80, 100 mg kg-1 soil) on different soil enzymes and microbial community structure. Results revealed that soil enzyme activities and microbial biomass had a uniform trend where the value increased up to the dose of 20 mg TiO2 NPs kg-1 soil and there onwards reduced drastically up to 100 mg TiO2 NPs kg-1 soil dose.